Cutaneous photobiology. The melanocyte vs. the sun: Who will win the final round?

Pigment Cell Research

Volumn 16, Issue 5, 2003, Pages 434-447

  Kadekaro, Ana Luisa ^a   Kavanagh, Renny J ^a   Wakamatsu, Kazumasa ^b   Ito, Shosuke ^b   Pipitone, Michelle A ^a   Abdel Malek, Zalfa A ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Apoptosis; DNA damage; Human melanocytes; Melanin; Melanoma; Photoprotection; Ultraviolet radiation

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; DNA; EUMELANIN; MELANIN; MITOGEN ACTIVATED PROTEIN KINASE; PHEOMELANIN; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; BRAF GENE; CANCER SUSCEPTIBILITY; CDKN2 GENE; CELL TRANSFORMATION; DNA DAMAGE; ENZYME ACTIVITY; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MC1R GENE; MELANOCYTE; MELANOMA; MELANOMA SUSCEPTIBILITY GENE; ONCOGENE; ONCOGENE RAS; RADIATION EXPOSURE; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SOLAR RADIATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

ANIMALS; DNA DAMAGE; DNA REPAIR; HUMANS; MELANINS; MELANOCYTES; MELANOMA; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; PHOTOBIOLOGY; RADIATION PROTECTION; SKIN; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 0041835985     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2003.00088.x     Document Type: Review

References (186)

1. Dillman AM. Photobiology of skin pigmentation. In: Levine N. Pigmentation and Pigmentary Disorders. Boca Raton: CRC Press, Inc.: 1993. pp. 61-94
2. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999;340:1341-1348
3. Redman JC. Stratospheric ozone depletion. Am J Dermatopathol 1987;9:457-458
4. Freeman SE, Hacham H, Gange RW, Maytum DJ, Sutherland JD, Sutherland BM. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci USA 1989;86:5605-5609
5. Mitchell DL, Nairn RS. The biology of the (6-4) photoproduct. Photochem Photobiol 1989;49:805-819
6. Mitchell DL, Jen J, Cleaver JE. Relative induction of cyclobutane dimers and cytosine photohydrates in DNA irradiated in vitro and in vivo with ultraviolet-C and ultraviolet-B light. Photochem Photobiol 1991;54:741-746
7. Gange RW, Rosen CF. UVA effects on mammalian skin and cells. Photochem Photobiol 1986;43:701-705
8. Kochevar IE, Pathak MA, Parrish JA. Photophysics, photochemistry, and photobiology. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF. Dermatology in General Medicine, Vol. 1. New York: McGraw-Hill; 1993. pp. 1627-1638
9. Kvam E, Tyrrell RM. Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis 1997;18:2379-2384
10. Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 1981;77:51-58
11. Bikle DD, Nemanic MK, Gee E, Elias P. 1,25 Dihydroxyvitamin D3 production by human keratinocytes. J Clin Invest 1986;78:557-566
12. Franklin WA, Haseltine WA. The role of the (6-4) photoproduct in ultraviolet light transition mutations in E. Coli. Mutat Res 1986;165:1-7
13. Young AR. The sunburn cell. Photodermatology 1987;4:127-134
14. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Lefell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1996;1:136-142
15. Aberer W, Schuler G, Stingl G, Honigsmann H, Wolff K. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 1981;76:202-210
16. Bestak R, Halliday GM. Chronic low-dose UVA irradiation induces local suppression of contact hypersensitivity, Langerhans cell depletion and suppressor cell activation in C3H/HeJ mice. Photochem Photobiol 1996;64:969-974
17. Kripke ML. Immunobiology of UV-radiation induced skin cancer. In: Parrish JA, Kripke ML, Morison WL. Photoimmunology. New York: Plenum Medical: 1983. p. 157
18. Epstein JH. Photocarcinogenesis, skin cancer and aging. J Am Acad Dermatol 1983;9:487-502
19. Sober AJ, Lew RA, Koh HK, Barnhill RL. Epidemiology of cutaneous melanoma. An update Dermatol Clin 1991;9:617-629
20. Pathak MA. Ultraviolet radiation and the development of nonmelanoma and melanoma skin cancer: Clinical and experimental evidence. Skin Pharmacol 1991;4(Suppl. 1):85-94
21. Black HS, de Gruijl FR, Forbes PD, Cleaver JE, Ananthaswamy HN, De Fabo EC, Ulrich SE, Tyrrell RM. Photocarcinogenesis: an overview. Photochem Photobiol 1997;40:29-47
22. Gilchrest BA, Rogers GS. Photoaging. In: Lim HW, Soter NA. Clinical Photomedicine. New York: Marcel Dekker, Inc.; 1993. pp. 95-111
23. Langley RG, Sober AJ. A clinical review of the evidence for the role of ultraviolet radiation in the etiology of cutaneous melanoma. Cancer Invest 1997;15:561-567
24. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992;267:24675-24680
25. Wakamatsu K, Graham A, Cook D, Thody AJ. Characterization of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res 1997;10:288-297
26. Suzuki I, Kato T, Motokawa T, Tomita Y, Nakamura E, Katagiri T. Increase of pro-opiomelanocortin mRNA prior to tyrosinase, tyrosinase-related protein 1, dopachrome tautomerase, Pmel-17/gp100, and P-protein mRNA in human skin after ultraviolet B irradiation. J Invest Dermatol 2002;118:73-78
27. Halaban R, Langdon R, Birchall N et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 1988;107:1611-1619
28. Kock A, Schwarz T, Kirnbauer R et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990;172:1609-1614
29. Pathak MA, Jimbow K, Fitzpatrick T. Photobiology of pigment cells. In: Seiji M. Phenotypic Expression in Pigment Cells. Tokyo, Japan: University of Tokyo Press; 1980. pp. 655-670
30. Hunt G, Donatien PD, Lunec J, Todd C, Kyne S, Thody AJ. Cultured human melanocytes respond to MSH peptides and ACTH. Pigment Cell Res 1994;7:217-221
31. Abdel-Malek ZA, Swope VB, Nordlund JJ, Medrano EE. Proliferation and propagation of human melanocytes in vitro are affected by donor age and anatomical site. Pigment Cell Res 1994;7:116-122
32. Ito S, Wakamatsu K. Quantitative analysis of eumelanin and pheomelanin in humans, mice and other animals: a comparative review. Pigment Cell Res 2003;16:523-531
33. Napolitano A, Vincensi MR, Di Donato P, Monfrecola G, Prota G. Microanalysis of melanins in mammalian hair by alkaline hydrogen peroxide degradation: Identification of a new structural marker of pheomelanins. J Invest Dermatol 2000;114:1141-1147
34. Prota G. Melanins, melanogenesis and melanocytes: looking at their functional significance from the chemist's viewpoint. Pigment Cell Res 2000;13:283-293
35. Szabo G. Racial differences in the fate of melanosomes in human epidermis. Nature 1969;222:1081
36. Halaban R, Pomerantz SH, Marshall S, Lambert DT, Lerner AB. Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol 1983;97:480-488
37. Iwata M, Corn T, Iwata S, Everett MA, Fuller BB. The relationship between tyrosinase activity and skin color in human foreskins. J Invest Dermatol 1990;95:9-15
38. Abdel-Malek Z, Swope V, Collins C, Boissy R, Zhao H, Nordlund J. Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes. J Cell Sci 1993;106:1323-1331
39. Pathak MA, Fitzpatrick TB. The role of natural photoprotective agents in human skin. In: Fitzpatrick TB, Pathak MA, Haber LC, Seiji M, Kukita A. Sunlight and Man. Tokyo: University of Tokyo Press: 1974. pp. 725-750
40. Kaidbey KH, Poh Agin P, Sayre RM, Kligman AM. Photoprotection by melanin - a comparison of black and Caucasian skin. J Am Acad Dermatol 1979;1:249-260
41. Olson RL, Nordquist J, Everett MA. The role of epidermal lysosomes in melanin physiology. Br J Dermatol 1970;83:189-199
42. Pathak MA, Hori Y, Szabo G, Fitzpatrick TB. The photobiology of melanin pigmentation in human skin. In: Kawamura T, Fitzpatrick TB, Seiji M. Biology of Normal and Abnormal Melanocytes. Baltimore: University Park Press; 1971. pp. 149-169
43. Kobayashi N, Nakagawa A, Muramatsu T et al. Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol 1998;110:806-810
44. Bustamante J, Bredeston L, Malanga G, Mordoh J. Role of melanin as a scavenger of active oxygen species. Pigment Cell Res 1993;6:348-353
45. Felix CC, Hyde JS, Sarna T, Sealy RC. Melanin photoreaction in aerated media: electron spin resonance evidence of production of superoxide and hydrogen peroxide. Biochem Biophys Res Commun 1978;84:335-341
46. Chedekel MR, Smith SK, Post PW, Pokora A, Vessell DL. Photodestruction of pheomelanin: role of oxygen. Proc Natl Acad Sci USA 1978;75:5395-5399
47. Sarna T. Properties and function of the ocular melanin - a photobiophysical view. J Photochem Photobiol B 1992;12:215-258
48. Menon IA, Persad S, Ranadive NS, Haberman HF. Photobiological effects of eumelanin and pheomelanin. In: Bagnara JT, Klaus SN, Paul E, Schartl M. Biological, Molecular and Clinical Aspects of Pigmentation. Tokyo: University of Tokyo Press; 1985: pp. 77-86
49. Cesarini JP. Photo-induced events in the human melanocytic system: photoaggression and photoprotection. [Review]. Pigment Cell Res 1988;1:223-233
50. Benedetto J-P, Ortonne J-P, Voulot C. Role of thiol compounds in mammalian melanin pigmentation: part I. J Invest Dermatol 1981;77:402-405
51. Benedetto JP, Ortonne JP, Voulot C, Khatchadourian C, Prota G, Thivolet J. Role of thiol compounds in mammalian melanin pigmentation. II. Glutathione and related enzymatic activities. J Invest Dermatol 1982;79:422-424
52. Connor MJ, Wheeler LA. Depletion of cutaneous glutathione by ultraviolet radiation. Photochem Photobiol 1987;46:239-245
53. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer 1995;75:667-673
54. Kricker A, Armstrong BK, English DR. Sun exposure and nonmelanocytic skin cancer. Cancer Causes Control 1994;5:367-392
55. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992;327:1649-1662
56. Forty-five years of cancer incidence in Connecticut: 1935-79. National Cancer Institute Monograph 70. Washington, DC: Government Printing Office, 1986
57. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol. 6. Lyon, France: International Agency for Research on Cancer; 1992
58. MacLennan R, Green AC, McLeod GRC, Martin NG. Increasing incidence of cutaneous melanoma in Queensland. Australia. J Natl Cancer Inst 1992;84:1427-1432
59. Fitzpatrick TB, Eisen AZ, Wolff K, Freedburg IM, Austen KF. Dermatology in General Medicine. New York: McGraw Hill, Inc., 1987
60. Friedmann PS, Gilchrest BA. Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol 1987;133:88-94
61. Musk P, Parsons PG. Resistance of pigmented human cells to killing by sunlight and oxygen radicals. Photochem Photobiol 1987;46:489-494
62. Kobayashi N, Muramatsu T, Yamashina Y, Shirai T, Ohnishi T, Mori T. Melanin reduces ultraviolet-induced DNA damage formation and killing rate in cultured human melanoma cells. J Invest Dermatol 1993;101:685-689
63. Yohn JJ, Lyons MB, Norris DA. Cultured human melanocytes from black and white donors have different sunlight and ultraviolet A radiation sensitivities. J Invest Dermatol 1992;99:454-459
64. Yohn JJ, Norris DA, Yrastorza DG et al. Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. J Invest Dermatol 1991;97:405-409
65. De Leeuw SM, Janssen S, Simons JWIM, Lohman PHM, Vermeer B-J, Schothorst AA. The UV action spectra for the clone-forming ability of cultured human melanocytes and keratinocytes. Photochem Photobiol 1994;59:430-436
66. Barker D, Dixon K, Medrano EE et al. Comparison of the responses of human melanocytes with different melanin contents to ultraviolet B irradiation. Cancer Res 1995;55:4041-4046
67. Smit NPM, Vink AA, Kolb RM et al. Melanin offers protection against induction of cyclobutane pyrimidine dimers and 6-4 photoproducts by UVB in cultured human melanocytes. Photochem Photobiol 2001;74:424-430
68. Sheehan JM, Cragg N, Chadwick CA, Potten CS, Young AR. Repeated ultraviolet exposure affords the same protection against DNA photodamage and erythema in human skin types II and IV but is associated with faster DNA repair in skin type IV. J Invest Dermatol 2002;118:825-829
69. Tadokoro T, Kobayashi N, Zmudzka BZ et al. UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin. FASEB J. 2003; Published online 8 April 2003:express article 10.1096/fj.02-0865fje
70. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 1996;274:1194-1197
71. Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996;271:24313-24316
72. Ono K, Han J. The p38 signal transduction pathway. Activation and function. Cell Signal 2000;12:1-13
73. Huang C, Ma W-Y. Maxinert A, Sun Y, Dong Z. p38 Kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J Biol Chem 1999;274:12229-12235
74. She Q-B, Ma W-Y, Zhong S, Dong Z. Activation of JNK1, RSK2, and MSK1 is involved in serine 112 phosphorylation of Bad by ultraviolet B radiation. J Biol Chem 2002;277:24039-24048
75. El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825
76. Waga S, Hannon GJ, Beach D, Stillman B. The p21 cyclin-dependent kinase inhibitor directly controls DNA replication via interaction with PCNA. Nature 1994;369:574-578
77. Liu M, Pelling JC. UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression. Oncogene 1995;10:1955-1960
78. Miyashita T, Krajewski S, Krajewska M et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805
79. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-816
80. Nevins JR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992;258:424-9
81. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331
82. Liu Z-G, Baskaran R, Lea-Chou ET et al. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 1996;384:273-276
83. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311
84. Smith ML, Chen I-T, Zhan Q, O'Connor PM, Fornace AJ Jr. Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 1995;10:1053-1059
85. Schulze A, Zerfass K, Spitkovsky D, Henglein B, Jansen-Durr P. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTSI. Oncogene 1994;9:3475-3482
86. Lukas J, Parry D, Aagaard L et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995;375:503-506
87. Tada A, Pereira E, Beitner Johnson D, Abdel-Malek ZA. Mitogen and stress induced signaling pathways in normal human melanocytes. J Invest Dermatol 2002;118:316-322
88. Funasaka Y, Boulton T, Cobb M et al. c-Kit-Kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 1992;3:197-209
89. Medrano EE, Yang F, Boissy RE et al. Terminal differentiation and senescence in the human melanocyte: repression of tyrosine-phosphorylation of the extracellular-signal regulated kinase 2 (ERK2) selectively defines the two phenotypes. Mol Biol Cell 1994;5:497-509
90. 133 kinase in human melanocytes. Cell Growth Differ 1995;6:291-302
91. Waf-1/SD1/Cip-1 protein. Cancer Res 1995;55:4047-4052
92. Abdel-Malek ZA, Pereira E, Shertzer HG et al. Evaluation of UVA-induced oxidative stress and genotoxicity in human melanocytes. J Invest Dermatol 2001;117:503
93. Murphy G, Young AR, Wulf HC, Kulms D, Schwarz T. The molecular determinants of sunburn cell formation. Exp Dermatol 2001;10:155-160
94. Wolf P, Cox P, Yarosh DB, Kripke ML. Sunscreens and T4N5 liposomes differ in their ability to protect against ultraviolet-induced sunburn cell formation, alterations of dendritic epidermal cells, and local suppression of contact hypersensitivity. J Invest Dermatol 1995;104:287-292
95. Schwarz A, Bhardwaj R, Aragane Y et al. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol 1995;104:922-927
96. Leverkus M, Yaar M, Gilchrest BA. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 1997;232:255-262
97. Tada A, Suzuki I, Im S et al. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ 1998;9:575-584
98. Klein-Parker HA, Warshawski L, Tron VA. Melanocytes in human skin express bcl-2 protein. J Cutan Pathol 1994;21:297-301
99. Plettenberg A, Ballaun C, Pammer J et al. Human melanocytes and melanoma cells constitutively express the bcl-2 proto-oncogene in situ and in cell culture. Am J Pathol 1995;146:651-659
100. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993;75:229-240
101. Swope VB, Abdel-Malek ZA, Kassem L, Nordlund JJ. Interleukins 1α and 6 and tumor necrosis factor-α are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 1991;96:180-185
102. Zhang XD, Nguyen T, Thomas WD, Sanders JE, Hersey P. Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett 2000;482:193-199
103. Wan YS, Wang ZQ, Shao Y, Voorhees JJ, Fisher GJ. Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int J Oncol 2001;18:461-466
104. Kennedy SG, Wagner AJ, Conzen SD et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 1997;11:701-713
105. Kandel ES, Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999; 253:210-229
106. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995;267:2003-2006
107. Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor 1 receptor, phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 1997;17:1595-1606
108. Blume-Jensen P, Janknecht R, Hunter T. The Kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr Biol 1998;8:779-782
109. Filippa N, Sable CL, Filloux C, Hemmings B, Van Obberghen E. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol Cell Biol 1999;19:4989-5000
110. Datta SR, Dudek H, Tao X et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-241
111. Cardone MH, Roy N, Stennicke HR et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318-1321
112. Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 1998;273:32377-32379
113. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 1999;9:601-604
114. Abdel-Malek ZA. α-Melanocortin and endothelin-1 are survival factors that inhibit UVB-induced apoptosis of human melanocytes. Pigment Cell Res 2002;15:47
115. Price ER, Horstmann MA, Wells AG et al. α-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem 1998;273:3042-33047
116. McGill GG, Horstmann M, Widlund HR et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002;109:707-718
117. Goding CR. Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 2000;14:1712-1728
118. Eller MS, Maeda T, Magnoni C, Atwal D, Gilchrest BA. Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci USA 1997;94:12627-12632
119. Nylander K, Bourdon J-C, Bray SE et al. Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J Pathol 2000;190:39-46
120. Khlgatian MK, Hadshiew IM, Asawanonda P et al. Tyrosinase gene expression is regulated by p53. J Invest Dermatol 2002;118:126-132
121. Bentley NJ, Eisen T, Goding CR. Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol 1994;14:7996-8006
122. Yasumoto K-I, Yokoyama K, Shibata K, Tomita Y, Shibahara S. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol Cell Biol 1994;14:8058-8070
123. Hemesath TJ, Steingrimsson E, McGill G et al. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 1994;8:2770-2780
124. Yavuzer U, Keenan E, Lowings P, Vachtenheim J, Currie G, Goding CR. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene 1995;10:123-134
125. Fang D, Tsuji Y, Setaluri V. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. Nucleic Acids Res 2002;30:3096-3106
126. Galibert M-D, Carreira S, Goding CR. The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression. EMBO J 2001;20:5022-5031
127. Gordon PR, Mansur CP, Gilchrest BA. Regulation of human melanocyte growth, dendricity, and melanization by keratinocyte derived factors. J Invest Dermatol 1989;92:565-572
128. Schauer E, Trautinger F, Kock A et al. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest 1994;93:2258-2262
129. Chakraborty AK, Funasaka Y, Slominski A et al. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta 1996;1313:130-138
130. Kupper TS, Chua AO, Flood P, McGuire J, Gubler U. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 1987;80:430-436
131. Duval C, Regnier M, Schmidt R. Distinct melanogenic response of human melanocytes in mono-culture, in co-culture with keratinocytes and in reconstructed epidermis, to UV exposure. Pigment Cell Res 2001;14:348-355
132. Yohn JJ, Morelli JG, Walchak SJ, Rundell KB, Norris DA, Zamora MR. Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol 1993;100:23-26
133. Pawelek JM, Lerner AB. 5,6-dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature 1978;276:627-628
134. Pawelek JM, Korner AM, Bergstrom A, Bolognia J. New regulators of melanin biosynthesis and the autodestruction of melanoma cells. Nature 1980;286:617-619
135. Suzuki I, Cone R, Im S, Nordlund J, Abdel-Malek Z. Binding capacity and activation of the MCl receptors by melanotropic hormones correlate directly with their mitogenic and melanogenic effects on human melanocytes. Endocrinology 1996;137:1627-1633
136. Abdel-Malek Z, Swope VB, Pallas J, Krug K, Nordlund JJ. Mitogenic, melanogenic and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens. J Cell Physiol 1992;150:416-425
137. Swope VB, Medrano EE, Smalara D, Abdel-Malek Z. Long-term proliferation of human melanocytes is supported by the physiologic mitogens α-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp Cell Res 1995;217:453-459
138. Abdel-Malek Z, Swope VB, Suzuki I et al. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 1995;92:1789-1793
139. Haycock JW, Rowe SJ, Cartledge S et al. α-Melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. J Biol Chem 2000;275:15629-15636
140. Im S, Moro O, Peng F et al. Activation of the cAMP pathway by α-melanotropin mediates the response of human melanocytes to UVB light. Cancer Res 1998;58:47-54
141. Imokawa G, Miyagishi M, Yada Y. Endothelin-1 as a new melanogen: Coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. J Invest Dermatol 1995;105: 32-37
142. Schwarz A, Stander S, Berneburg M et al. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nature Cell Biol 2002;4:26-31
143. Decraene D, Agostinis P, Bouillon R, Degreef H, Garmyn M. Insulin-like growth factor-1-mediated AKT activation postpones the onset of ultraviolet B-induced apoptosis, providing more time for cyclobutane thymine dimer removal in primary human keratinocytes. J Biol Chem 2002;277:32587-32595
144. Nelemans PJ, Groenendal H, Kiemeney LA, Rampen FH, Ruiter DJ, Verbeek AL. Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspec 1993;101:252-255
145. Holman CDJ, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986;76:403-414
146. Bentham G, Aase A. Incidence of malignant melanoma of the skin in Norway, 1955-1989: associations with solar ultraviolet radiation, income and holidays abroad. Int J Epidemiol 1996;25:1132-1138
147. Weinstock MA. Controversies in the role of sunlight in the pathogenesis of cutaneous melanoma. Photochem Photobiol 1996;63:406-410
148. Brash DE, Rudolph JA, Simon JA et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991;88:10124-10128
149. Jonason AS, Kunala S, Price GJ et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996;93:14025-14029
150. Ziegler A, Jonason AS, Leffell DJ et al. Sunburn and p53 in the onset of skin cancer. Nature 1994;372:773-776
151. Lubbe J, Reichel M, Burg G, Kleihues P. Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol 1994; 102:819-821
152. Montano X, Shamsher M, Whitehead P, Dawson K, Newton J. Analysis of p53 in human cutaneous melanoma cell lines. Oncogene 1994;9:1455-1459
153. Pollock PM, Yu F, Qiu L, Parsons PG, Hayward NK. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines. Oncogene 1995;11:663-668
154. Flores JF, Walker GJ, Glendening JM et al. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res 1996;56:5023-5032
155. Kamb A, Gruis NA, Weaver-Feldhaus J et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-440
156. Setlow RB, Grist E, Thompson K, Woodhead AD. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 1993;90:6666-6670
157. Drobetsky EA, Turcotte J, Chateauneuf A. A role for ultraviolet A in solar mutagenesis. Proc Natl Acad Sci USA 1995;92:2350-2354
158. Setlow RB, Woodhead AD. Temporal changes in the incidence of malignant melanoma: Explanation from action spectra. Mutat Res 1994;307:365-374
159. Ley RD. Ultraviolet radiation A-induced precursors of cutaneous melanoma in Monodelphis domestica. Cancer Res 1997;57:3682-3684
160. Aubin F, Donawho CK, Kripke ML. Effect of psoralen plus ultraviolet A radiation on in vivo growth of melanoma cells. Cancer Res 1991;51:5893-5897
161. Beitner H. Clinical and experimental aspects of long-wave ultraviolet (UVA) irradiation of human skin. Acta Derm Venereol Suppl (Stockh) 1986;123:1-56
162. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968;218:652-656
163. Setlow RB, Regan JD, German J, Carrier WL. Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. Proc Natl Acad Sci USA 1969;64:1035-1041
164. Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 1993;90:5889-5892
165. Davies H, Bignell GR, Cox C et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-954
166. Brose MS, Volpe P, Feldman M et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 2002;62:6997-7000
167. Pollock PM, Harper UL, Hansen KS et al. High frequency of BRAF mutations in nevi. Nat Genet 2003;33:19-20
168. Dracopoli NC, Fountain JW. CDKN2 mutations in melanoma. Cancer Surv 1996;26:115-132
169. Stone S, Jiang P, Dayananth P et al. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 1995;55:2988-2994
170. Mao L, Merlo A, Bedi G et al. A novel p16INK4A transcript. Cancer Res 1995;55:2995-2997
171. Hall M, Bates S, Peters G. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 1995;11:1581-1588
172. Coleman KG, Wautlet BS, Morrissey D et al. Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J Biol Chem 1997;272:18869-18874
173. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997;387:296-299
174. Pomerantz J, Schreiber-Agus N, Liegeois NJ et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998;92:713-723
175. de Stanchina E, McCurrach ME, Zindy F et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev 1998;12:2434-2442
176. Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturm RA. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 1997;6:1891-1897
177. Smith R, Healy E, Siddiqui S et al. Melanocortin 1 receptor variants in Irish population. J Invest Dermatol 1998;111:119-122
178. Sturm RA, Box NF, Ramsay M. Human pigmentation genetics: the difference is only skin deep. Bioessays 1998;20:712-721
179. Rana BK, Hewett-Emmett D, Jin L et al. High polymorphism at the human melanocortin 1 receptor locus. Genetics 1999;151:1547-1557
180. Harding RM, Healy E, Ray AJ et al. Evidence for variable selective pressures at MC1R. Am J Hum Genet 2000;66:1351-1361
181. Palmer JS, Duffy DL, Box NF et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000;66:176-186
182. Box NF, Duffy DL, Chen W et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations Am J Hum Genet 2001;69:765-773
183. van der Velden PA, Sandkuijl LA, Bergman W et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001;69:774-779
184. Scott MC, Wakamatsu K, Ito S et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to ultraviolet radiation. J Cell Sci 2002;115:2349-2355.
185. Ito S, Fujita K. Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. Anal Biochem 1985;144:527-536
186. Ozeki H, Ito S, Wakamatsu K, Thody AJ. Spectrophotometric characterization of eumelanin and pheomelanin in hair. Pigment Cell Res 1996;9:265-270